about
A novel mutation in two families with limb-girdle muscular dystrophy type 2CCell-seeding techniques in vascular tissue engineeringTissue-engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vesselChallenges in translating vascular tissue engineering to the pediatric clinic.A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts.Determining the fate of seeded cells in venous tissue-engineered vascular grafts using serial MRICharacterization of the natural history of extracellular matrix production in tissue-engineered vascular grafts during neovessel formation.Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts.Vascular tissue engineering: towards the next generation vascular grafts.Gastroesophageal Reflux Burden, Even in Children That Aspirate, Does Not Increase Pediatric Hospitalization.Oropharyngeal Dysphagia Is Strongly Correlated With Apparent Life-Threatening Events.TGFβR1 inhibition blocks the formation of stenosis in tissue-engineered vascular grafts.Feeding Interventions are Associated with Improved Outcomes in Children with Laryngeal PenetrationAssociation of Proton Pump Inhibitors With Hospitalization Risk in Children With Oropharyngeal DysphagiaPresenting Signs and Symptoms do not Predict Aspiration Risk in ChildrenClinical Aspects of Thickeners for Pediatric Gastroesophageal Reflux and Oropharyngeal DysphagiaThe Impact of the American Academy of Pediatrics Brief Resolved Unexplained Event Guidelines on Gastrointestinal Testing and Prescribing Practices
P50
Q28251232-9E6268EA-5C9D-40A3-B94B-CC98A755E6C2Q34160631-825EE04E-BBCF-4B51-9514-B4B9F81000E2Q35105356-9607BAD3-6166-4DDB-8729-210E1702FD53Q35486978-12296C5B-41BA-4CC7-AA3F-45B9308A1A2EQ35609601-1E929060-E455-4350-AC15-D0EA0999F98AQ35609635-A221E438-1742-4A9A-B581-E5FF83E615AFQ35671324-B90C4113-28C7-477E-A8F9-7A1CEE46FD38Q35906795-E9804DCD-8554-4E2D-BCFD-740C0822C2E6Q37855213-E3F6F3A6-AB25-47E8-9CA7-9A6598CD0F83Q42067221-19211997-776C-481D-99E2-312CA41027B7Q50571268-B670AECF-B507-4769-97FE-A45B291FFA39Q53318880-CE242E71-DFB2-47E5-9FD6-378DD32E7951Q57471651-43175AFD-F136-460A-9839-D7EED2EFF2F7Q57476362-15DCED90-9A48-4A94-98CA-EC1D5770FB75Q89364597-CB3C14E2-9A31-4ADD-971D-41F33BD9FABCQ92100060-4FCE4C04-E0D6-4784-AE58-791CC20A2332Q92133742-E0A350F8-50DA-4FD9-B367-019DF475627E
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Daniel R Duncan
@ast
Daniel R Duncan
@en
Daniel R Duncan
@es
Daniel R Duncan
@nl
type
label
Daniel R Duncan
@ast
Daniel R Duncan
@en
Daniel R Duncan
@es
Daniel R Duncan
@nl
prefLabel
Daniel R Duncan
@ast
Daniel R Duncan
@en
Daniel R Duncan
@es
Daniel R Duncan
@nl
P106
P1153
36479776500
P21
P31
P496
0000-0003-4771-8901